Impact of Substituents on Excited-State and Photosensitizing Properties in Cationic Iridium(III) Complexes with Ligands of Coumarin 6.

ABSTRACT

A series of bis-cyclometalated cationic iridium (Ir) complexes were synthesized employing two coumarin 6 ligands and a 2,2'-bipyridine (bpy) with various substituents as new sensitizers, realizing both features of strong visible-light absorption and long-lived excited state. Complexes 2-4, with electron-donating methyl and methoxy groups, absorbed visible light strongly (ε 126 000-132 000 M(-1) cm(-1)) and exhibited room-temperature phosphorescence with remarkably long lifetimes (21-23 µs) in dichloromethane. In contrast, the excited state of prototype complex 1 without any substituents was short-lived, particularly in highly polar acetonitrile. Phosphorescence of complex 5 with the strong electron-withdrawing CF3 groups was too weak to be detected at room temperature even in less polar dichloromethane. The triplet energies of their coumarin ligand-centered ((3)LC) phosphorescent states were almost invariable, demonstrating that selective tuning of the excited-state lifetime is possible through this "simple chemical modification of the bpy ligand" (we name it the "SCMB" method). The spectroscopic and computational investigations in this study suggest that a potential source of the nonradiative deactivation is a triplet ligand-to-ligand charge-transfer state ((3)LLCT state, coumarin 6 → bpy) and lead us to conclude that the energy level of this dark (3)LLCT state, as well as its thermal population, is largely dependent on the substituents and solvent polarity. In addition, the significant difference in excited-state lifetime was reflected in the photosensitizing ability of complexes 1-5 in visible-light-driven hydrogen generation using sodium ascorbate and a cobalt(III) diglyoxime complex as an electron donor and a water-reduction catalyst, respectively. This study suggests that the SCMB method should be generally effective in controlling the excited state of other bis-cyclometalated cationic Ir(III) complexes.